Other News

The world’s first gene therapy trial for a genetic cause of blindness known as choroideremia has shown positive results. The trial, supported by NIHR Oxford Biomedical Research Centre (BRC), began in 2011 at the Oxford Eye Hospital, part of the Oxford University Hospitals NHS Foundation Trust. Reported on Monday 8 October in the Nature Medicine … Read more

A one-day event in Oxford today is offering a unique opportunity to for healthcare industry figures from the US and Europe to engage with two of the world’s leading universities to explore the many ways healthcare will be transformed. The Healthcare Technologies of the Future Conference is being jointly organised by the University of Oxford … Read more

The leading academic who has overseen the expansion of world-leading medical research at the NIHR Oxford Biomedical Research Centre (BRC) for the past nine years is stepping down. Professor Keith Channon will be replaced as Director of the Oxford BRC by Professor Helen McShane, a leading vaccine specialist. Prof Channon was appointed to lead the … Read more

A study supported by the NIHR Oxford Biomedical Research Centre has concluded that iron supplements on their own are not enough to efficiently tackle anaemia in places with high infection burdens. In a paper published in The BMJ, Prof Hal Drakesmith from the MRC Human Immunology Unit, based at Oxford’s John Radcliffe Hospital, and collaborators in Australia … Read more

The first ever drug specifically designed to prevent migraines in adults has been approved by the European Medicines Agency (EMA), and the head of the Oxford Headache Centre has said the news represents a new approach in treating the condition. The EMA granted a licence for the use of erenumab, manufactured by Novartis under the … Read more

About one billion people worldwide take regular aspirin, usually to prevent heart attacks or strokes. Writing in The Lancet, researchers have shown that ‘one-dose-fits-all’ use of aspirin to prevent heart attacks, stroke or cancer, is ineffective or harmful in the majority of people, and that a more tailored strategy is required. Daily aspirin reduces blood clots … Read more

Pregnant women are being invited by the University of Oxford and the NHS to take part in the world’s first clinical trial to prevent type 1 diabetes in babies and infants. Researchers supported by the NIHR Oxford Biomedical Research Centre want to find out if giving small amounts of insulin to babies on the trial … Read more

The Department of Health and Social Care’s Chief Scientific Adviser, Prof Chris Whitty, visited Oxford on Monday 2nd July to find out about the world-leading research taking place there and to meet young medical researchers starting out on their career. After a meeting at the John Radcliffe Hospital with senior leaders of Oxford University Hospitals … Read more